INSMED INC (INSM)
US4576693075 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to INSM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 42.93. This target is 80.39% above the current price.
INSM was analyzed by 18 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about INSM.
In the previous month the buy percentage consensus was at a similar level.
INSM was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-20 | JP Morgan | Reiterate | Overweight |
| 2023-09-21 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-09-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023-09-06 | B of A Securities | Maintains | Buy -> Buy |
| 2023-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-05 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-08-04 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-26 | Guggenheim | Initiate | Buy |
| 2023-05-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-24 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-02-24 | Credit Suisse | Reiterate | Outperform |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-20 | Barclays | Maintains | Overweight |
| 2023-01-09 | Goldman Sachs | Maintains | Buy |
| 2022-12-09 | Mizuho | Initiate | Buy |
| 2022-12-08 | Barclays | Initiate | Overweight |
| 2022-12-07 | Barclays | Initiate | Overweight |
| 2022-11-18 | B of A Securities | Initiate | Buy |
| 2022-10-27 | SVB Leerink | Maintains | Outperform |
| 2022-10-25 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-10-21 | Cowen & Co. | Maintains | Outperform |
| 2022-07-15 | Morgan Stanley | Maintains | Overweight |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-04-27 | Goldman Sachs | Initiate | Buy |
| 2022-02-22 | SVB Leerink | Maintains | Outperform |
| 2021-12-06 | JP Morgan | Initiate | Overweight |
| 2021-10-08 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-10 | Morgan Stanley | Maintains | Overweight |